Avacta Acquires Coris Bioconcept
With the acquisition, Avacta gains Coris’ product portfolio including diagnostic tests for respiratory, gastro-enteric, and blood-borne pathogens and for the detection of antibiotic resistance markers.
With the acquisition, Avacta gains Coris’ product portfolio including diagnostic tests for respiratory, gastro-enteric, and blood-borne pathogens and for the detection of antibiotic resistance markers.
In addition to expanding its facility, MCI Diagnostic Center is launching a recruitment campaign seeking candidates for every department.
INTEGRA Biosciences acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for NGS protocols.
Molecular Designs announced the completion of a recent ISO 13485:2016 inspection and certification of its Quality Management System.
Read MoreA co-marketing agreement with Biosero and Analytik Jena will allow them to promote applications of their combined laboratory automation tech.
Read MoreQuest Diagnostics partnered with the regional integrated healthcare system in Pennsylvania to help enhance its diagnostic services.
Read MoreRoche has expanded its collaboration with Janssen Biotech to create companion diagnostics for targeted therapies.
Read MoreAlercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read MoreMatrix Medical Network and Karrington Clinical Laboratory announced the sale of the Matrix Clinical Laboratory to Karrington.
Read MoreLinusBio raised over $16 million to deliver a novel platform that bridges genomics, the environment, and biological response.
Read MoreNuraLogix unveiled a platform that performs continuous health and vital sign measurements while on a video telemedicine call.
Read MoreHelix announced a global strategic partnership with QIAGEN N.V. to jointly develop companion diagnostics for hereditary diseases.
Read MoreSiPhox Health is developing a home-based diagnostic solution that offers consumers lab-grade results for proteins and hormones.
Read MoreQuest Diagnostics and Northern Light Health are collaborating to broaden access to affordable care for communities in Maine.
Read MoreAt the request of IIROC, Asep Medical Holdings clarified its disclosure regarding its diagnostic and therapeutic technologies.
Read MoreRoche has appointed Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023.
Read MoreCOLA announces the American Medical Association’s (AMA) appointment of Madelyn E. Butler, MD, to COLA’s Board of Directors.
Read MoreWerfen is set to acquire Immucor, a privately held corporation with a strong presence in transfusion and transplant in vitro diagnostics.
Read More